April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Novavax (NVAX) stock forecast for 2025
Updated: April 25, 2024 (12:21)
Sector: HealthcareThe share price of Novavax, Inc. (NVAX) now
50/200 Day Moving Average: $4.689 / $6.08
This figure corresponds to the Average Price over the previous 50/200 days. For Novavax stocks, the 50-day moving average is the resistance level today.
For Novavax stocks, the 200-day moving average is the resistance level today.
Are you interested in Novavax, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Novavax stock price in 2025. How much will one Novavax share be worth in 2025? Is it worth taking profit / loss on NVAX stock now or waiting? What are analysts' forecasts for Novavax stock?
We forecast Novavax stock performance using neural networks based on historical data on NVAX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Novavax, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Novavax analysts is $15.4. Today 200 Day Moving Average is the resistance level (6.08 $). 50 Day Moving Average is the resistance level (4.689 $).
Historical and forecast chart of Novavax, Inc. stock
The chart below shows the historical price of Novavax stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the NVAX stock price can be found in the table below.
Novavex, Inc. Together with its subsidiary Novavax AB, a late-stage biotechnology company, it discovers, develops and commercializes vaccines to prevent serious infectious diseases. The company’s leading vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate, which is in stage III clinical trials to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in phase III clinical trials for the treatment of seasonal influenza in the elderly. Its leading adjuvant is Matrix-M, which is used to enable the vaccine to enhance the amplitude of the immune response and qualitatively change it, and to allow the immune system to attack microorganisms, and also to allow immunization with much smaller doses of antigen. The company is also developing the RSV F vaccine for the elderly (60 years and older), which is in phase II clinical trials, as well as for healthy children aged six months to five years, who are in phase I clinical trials. In addition, it is developing candidate nanoparticle vaccines for clinical trials against the Ebola virus, which is in clinical trials stage I; and a combined respiratory vaccine to protect against influenza and RSV. In addition, the company is developing a COVID-19 vaccine against the pneumonia-like coronavirus, which is in the preclinical stage. Novavex, Inc. the company was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax (NVAX) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.23 | 2.54 | 3.75 | 32.10 % |
| Feb | 2.52 | 2.27 | 2.89 | 21.19 % |
| Mar | 2.36 | 2.07 | 2.69 | 23.14 % |
| Apr | 2.08 | 1.91 | 2.46 | 22.37 % |
| May | 2.58 | 2.29 | 3.01 | 24.14 % |
| Jun | 3.07 | 2.88 | 3.45 | 16.78 % |
| Jul | 3.62 | 3.18 | 4.38 | 27.52 % |
| Aug | 3.14 | 2.75 | 3.61 | 24.00 % |
| Sep | 3.29 | 2.88 | 3.61 | 20.26 % |
| Oct | 4.24 | 3.41 | 5.08 | 32.80 % |
| Nov | 3.63 | 2.80 | 4.02 | 30.32 % |
| Dec | 3.51 | 2.86 | 4.07 | 29.77 % |
Novavax information and performance
20 FIRSTFIELD ROAD, GAITHERSBURG, MD, US
Market capitalization of the Novavax, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of NVAX shares in the company outstanding by the market price of one share.
EBITDA of Novavax is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Novavax price target for 2025 by month
Target values for the price of one Novavax share for Jan 2025.
In Jan, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 32.096% volatility is expected.
Pessimistic target level: 2.54
Optimistic target level: 3.75
Target values for the price of one Novavax share for Feb 2025.
In Feb, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 21.186% volatility is expected.
Pessimistic target level: 2.27
Optimistic target level: 2.89
Target values for the price of one Novavax share for Mar 2025.
In Mar, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 23.138% volatility is expected.
Pessimistic target level: 2.07
Optimistic target level: 2.69
Target values for the price of one Novavax share for Apr 2025.
In Apr, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 22.373% volatility is expected.
Pessimistic target level: 1.91
Optimistic target level: 2.46
Target values for the price of one Novavax share for May 2025.
In May, the Positive dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 24.144% volatility is expected.
Pessimistic target level: 2.29
Optimistic target level: 3.01
Target values for the price of one Novavax share for Jun 2025.
In Jun, the Positive dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 16.785% volatility is expected.
Pessimistic target level: 2.88
Optimistic target level: 3.45
Target values for the price of one Novavax share for Jul 2025.
In Jul, the Positive dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 27.521% volatility is expected.
Pessimistic target level: 3.18
Optimistic target level: 4.38
Target values for the price of one Novavax share for Aug 2025.
In Aug, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 24.000% volatility is expected.
Pessimistic target level: 2.75
Optimistic target level: 3.61
Target values for the price of one Novavax share for Sep 2025.
In Sep, the Positive dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 20.255% volatility is expected.
Pessimistic target level: 2.88
Optimistic target level: 3.61
Target values for the price of one Novavax share for Oct 2025.
In Oct, the Positive dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 32.805% volatility is expected.
Pessimistic target level: 3.41
Optimistic target level: 5.08
Target values for the price of one Novavax share for Nov 2025.
In Nov, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 30.325% volatility is expected.
Pessimistic target level: 2.80
Optimistic target level: 4.02
Target values for the price of one Novavax share for Dec 2025.
In Dec, the Negative dynamics for Novavax, Inc. shares will prevail with possible monthly volatility of 29.767% volatility is expected.
Pessimistic target level: 2.86
Optimistic target level: 4.07
Novavax (NVAX) stock dividend
Novavax last paid dividends on 01/01/1970. The next scheduled payment will be on 05/10/2019. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
